InvestorsHub Logo
Followers 4
Posts 361
Boards Moderated 0
Alias Born 07/28/2018

Re: None

Tuesday, 11/16/2021 12:27:06 PM

Tuesday, November 16, 2021 12:27:06 PM

Post# of 403039
About the Brilaciden-Oral Mucositis PIII study

With my limited DD at this time, it looks to me like a Brilaciden-Oral Mucositis ( B-OM) Phase 3 study is just a pipe dream at this point.

It's possible IPIX and/or IPIX + AlphaSigma (A/S) might be working on something, and there could be a PR or actual clinical trial filings any day now.

If that is the case, then IMO, this sell-off in IPIX is producing an insanely good "Fire-Sale Price" for buyers right now. (1)

However . . . it appears to me that"

We shareholders have NO EVIDENCE of an actual B-OM PIII Trial even being seriously considered - nothing more than a few stray sentences referencing the idea, buried in PRs of the COVID trials.

But we have No evidence of an actual "plan":

No PR has been issued specific to this trial, describing any sort of plan.

No filings for a B-OM PIII at clinicaltrials.gov.

AlphaSigma's R&D page is vague (and that is being kind).

No evidence of any sort of behind-the-scenes execution of a plan. For example :

___a) no evidence of clinics contacted, or any willing to publicly state their willingness to participate in trials.

___b) no evidence of ANY actual involvement of A/S in planning a trial (or some combination of IPIX + A/S + some other BP).
----------------------------------------

AlphaSigma:
(2) A/P Research Page: It says nothing about Brilaciden. Under "Gastroenterology" it says they have:

a) "5 Projects, three of which are in clinical development" and then they list: "Normix, Tixteller, Xifaxan (rifaximin) Fully developed by Alfasigma Indicated for Hepatic Encephalopaty, Traveler’s diarrhea, IBS."

b) and lower on the page: Rifaximin - is one of the most effective microbiome modifier on the market - Irritable Bowel Disease, Hepatic Encephalopathy

------------------------------

This above is the gist - there is more on the background of Oral Mucositis (the chemotherapy market is ENORMOUS and B looks like it could really make a HUGE difference in Quality of Life for patients - see the Full post on Reddit's IPIX subreddit


You don't need an Reddit account to read this post
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent IPIX News